Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth ▾	Diluted EPS
RCUS	Arcus Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$247.00M	-$353.00M	-142.9%	-55.9%	-4.3%	-$3.29
PBH	Prestige Consumer Healthcare Inc. Manufacturing · Year ended 2026-03-31 · USD	$1.09B	$190.30M	17.5%	10.1%	-4.3%	$3.91
ALKS	Alkermes plc. Manufacturing · Year ended 2025-12-31 · USD	$1.48B	$241.66M	16.4%	13.3%	-5.2%	$1.43
SPRY	ARS Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$84.28M	-$171.30M	-203.3%	-149.9%	-5.5%	-$1.74
IGC	IGC Pharma, Inc. Manufacturing · Year ended 2025-03-31 · USD	$1.27M	-$7.12M	-560.3%	-112.5%	-5.5%	-$0.09
JANX	Janux Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.00M	-$113.62M	n/m	-11.9%	-5.6%	-$1.83
LAB	Standard Biotools Inc. Manufacturing · Year ended 2025-12-31 · USD	$85.33M	-$74.90M	-87.8%	-17.7%	-6.2%	-$0.20
AMRN	Amarin Corp PLC Manufacturing · Year ended 2025-12-31 · USD	$213.65M	-$38.80M	-18.2%	-8.4%	-6.5%	-$0.09
CPHI	China Pharma Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$4.14M	-$3.19M	-76.9%	-14.0%	-8.5%	-$0.74
CVSI	CV Sciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$13.79M	-$958.0K	-6.9%	-65.3%	-12.2%	-$0.01
HCM	HUTCHMED (China) Ltd Manufacturing · Year ended 2025-12-31 · USD	$548.51M	$456.91M	83.3%	36.5%	-13.0%	$0.52
AYTU	Aytu Biopharma, Inc Manufacturing · Year ended 2026-06-30 · USD	$57.57M	-$14.25M	-24.8%	-40.4%	-13.3%	n/a
PYXS	Pyxis Oncology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$13.86M	-$79.62M	-574.5%	-149.1%	-14.2%	-$1.28
OPK	Opko Health, Inc. Manufacturing · Year ended 2025-12-31 · USD	$606.88M	-$225.68M	-37.2%	-17.8%	-14.9%	-$0.30
IRWD	Ironwood Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$296.15M	$24.02M	8.1%	n/a	-15.7%	$0.15
OCUL	Ocular Therapeutix, Inc Manufacturing · Year ended 2025-12-31 · USD	$51.95M	-$265.94M	-511.9%	-40.6%	-18.5%	-$1.42
INBP	Integrated Biopharma Inc Manufacturing · Year ended 2026-06-30 · USD	$43.87M	-$2.84M	-6.5%	-16.1%	-19.3%	-$0.09
LFVN	Lifevantage Corp Manufacturing · Year ended 2026-06-30 · USD	$182.59M	$5.07M	2.8%	15.1%	-20.1%	$0.40
AQST	Aquestive Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$44.55M	-$83.78M	-188.1%	n/a	-22.6%	-$0.78
IMNM	Immunome Inc. Manufacturing · Year ended 2025-12-31 · USD	$6.94M	-$212.39M	n/m	-33.5%	-23.2%	-$2.43
EMMA	Emmaus Life Sciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$12.45M	-$7.49M	-60.2%	n/a	-25.2%	-$0.12
CASIF	CASI Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$20.71M	-$48.06M	-232.0%	n/a	-27.4%	-$2.59
MRVI	Maravai Lifesciences Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$185.74M	-$130.77M	-70.4%	-61.6%	-28.3%	-$0.90
EBS	Emergent BioSolutions Inc. Manufacturing · Year ended 2025-12-31 · USD	$742.90M	$52.60M	7.1%	10.1%	-28.8%	$0.93
RMTI	Rockwell Medical, Inc. Manufacturing · Year ended 2025-12-31 · USD	$69.26M	-$5.31M	-7.7%	-14.4%	-31.8%	-$0.15

Rows per page: 2550 100